Role of Positron Emission Tomography/Computed Tomography in Epithelial Ovarian Cancer-Reference-Cited by-同舟云学术

Role of Positron Emission Tomography/Computed Tomography in Epithelial Ovarian Cancer

Published:2023 Issue:4 Volume:38 Page:366-375
ISSN:0972-3919
Container-title:Indian Journal of Nuclear Medicine
language:en
Short-container-title:

Author:

Chandra Rudrika¹,Kumari Sarita¹,Bhatla Neerja²,Kumar Rakesh³,Tiwari Abhinav⁴,Sachani Hemant⁵,Kumar Lalit⁶

Affiliation:

1. Department of Obstetrics and Gynaecology, Division of Gynaecologic Oncology, All India Institute of Medical Sciences, New Delhi, India

2. Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India

3. Department of Nuclear Medicine, Division of Diagnostic Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India

4. Department of Medicine, Base Hospital, Delhi Cantt, India

5. Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India

6. Department of Medical Oncology, BRA IRCH, All India Institute of Medical Sciences, New Delhi, India

Abstract

Ovarian cancer (OC) is the most lethal gynecological malignancy with majority of cases diagnosed in advanced stages and associated with high morbidity and mortality. Positron emission tomography/computed tomography (PET/CT) has emerged as an integral part of the management of several nongynecological cancers. We used PubMed search engine using MeSH words “ovarian cancer” and “PET/CT” and reviewed the current status of PET/CT in epithelial OC. Its application related to ovarian tumor including adnexal mass evaluation, baseline staging, as a triaging tool for upfront surgery or neoadjuvant chemotherapy, for response assessment and prognostication, and for relapse detection and treatment planning has been highlighted. we highlight the current guidelines and newer upcoming PET modalities and radiotracers.

Publisher

Medknow

Subject

Radiology, Nuclear Medicine and imaging

Reference48 articles.

1. Global Cancer Observatory

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Ovarian Cancer Screening and Mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomised Controlled Trial – ScienceDirect

4. Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial;Buys;JAMA,2011

5. The metabolism of tumors in the body;Warburg;J Gen Physiol,1927